Vivid Seats Inc. (SEAT) stock: key figures, P/E, revenue and dividend
Communication Services · United States · ISIN US92854T2096
Vivid Seats Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 450.51 m USD |
| EBIT | 446.14 m USD |
| Net income | 806.05 m USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Vivid Seats Inc.
Vivid Seats Inc. operates as an online ticket marketplace in the United States, Canada, and Japan. It operates in two segments, Marketplace and Resale. The Marketplace segment acts as an intermediary between event ticket buyers and sellers through its website and mobile applications, including Vivid Seats; Vegas.com, an online ticket marketplace for shows, attractions, tours, flights, and hotels in Las Vegas; Wavedash, an online ticket marketplace in Tokyo, Japan; and Vivid Picks, a real-money daily fantasy sports mobile application with social and gamification features. This segment also offers Skybox, a proprietary enterprise resource planning tool that helps ticket sellers manage ticket inventories, adjust pricing, and fulfill orders across multiple ticket resale marketplaces; and sells tickets for sports, concerts, theater events, and other live events. The Resale segment acquires tickets to resell on secondary ticket marketplaces; and provides internal research and development support for Skybox and to deliver seller software and tools. The company was founded in 2001 and is headquartered in Chicago, Illinois.
More stocks
- Vicapsys Life Sciences, Inc. (VICP)
- AmBase Corp (ABCP)
- Sphere 3D Corp. (ANY)
- MERCER INTERNATIONAL INC. (MERC)
- Beeline Holdings, Inc. (BLNE)
- Sentinel Holdings Ltd. (SNTL)
- Bolt Biotherapeutics, Inc. (BOLT)
- Tvardi Therapeutics, Inc. (TVRD)
- TAO Synergies Inc. (TAOX)
- T-REX Acquisition Corp. (TRXA)
- ACTUATE THERAPEUTICS, INC. (ACTU)
- ClearSign Technologies Corp (CLIR)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.